Patersons latest comment by their analyst
Valuation - The fundamentals of the projects remain unchanged
but we have added the dilutive impact of York acquisition and the 18M options with the convertible note. We have also applied a country risk factor of 25% (0.75x NAV). We retain our Buy recommendation with a revised price target of $0.26/share.